TNL Mediagene [TNMG] vs John Wiley & Sons [WLYB] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: TNL Mediagene wins in 6 metrics, John Wiley & Sons wins in 7 metrics, with 0 ties. John Wiley & Sons appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTNL MediageneJohn Wiley & SonsBetter
P/E Ratio (TTM)N/A22.86N/A
Price-to-Book Ratio0.212.95TNL Mediagene
Debt-to-Equity Ratio0.64126.20TNL Mediagene
PEG RatioN/A-0.03N/A
EV/EBITDA-0.659.89TNL Mediagene
Profit Margin (TTM)36.58%5.82%TNL Mediagene
Operating Margin (TTM)-159.10%7.96%John Wiley & Sons
EBITDA Margin (TTM)N/A7.96%N/A
Return on Equity-233.51%13.45%John Wiley & Sons
Return on Assets (TTM)-91.49%5.78%John Wiley & Sons
Free Cash Flow (TTM)$-10.58M$119.82MJohn Wiley & Sons
1-Year Return-97.44%-19.14%John Wiley & Sons
Price-to-Sales Ratio (TTM)0.201.30TNL Mediagene
Enterprise Value$29.03M$3.01BJohn Wiley & Sons
EV/Revenue Ratio0.601.80TNL Mediagene
Gross Profit Margin (TTM)N/A72.46%N/A
Revenue per Share (TTM)N/A$31N/A
Earnings per Share (Diluted)$-3.46$1.78John Wiley & Sons
Beta (Stock Volatility)N/A1.04N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

TNL Mediagene vs John Wiley & Sons Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TNL Mediagene3.14%11.11%-3.23%-37.50%-42.31%-95.94%
John Wiley & Sons0.00%0.00%0.43%-9.38%-5.32%-9.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TNL Mediagene-97.44%-97.44%-97.44%-97.44%-97.44%-97.44%
John Wiley & Sons-19.14%4.19%22.95%-21.68%-16.63%-16.63%

News Based Sentiment: TNL Mediagene vs John Wiley & Sons

TNL Mediagene

News sentiment data is not available for TNL Mediagene at this time.

John Wiley & Sons

News based Sentiment: MIXED

October was a mixed month for John Wiley & Sons, marked by strong financial results that exceeded expectations, but tempered by a stock downgrade, a significant increase in short interest, and governance concerns raised during a shareholder vote. These conflicting signals create a complex investment picture.

View John Wiley & Sons News Sentiment Analysis

Performance & Financial Health Analysis: TNL Mediagene vs John Wiley & Sons

MetricTNMGWLYB
Market Information
Market Cap i$9.54M$2.13B
Market Cap CategoryMicro capMid cap
10 Day Avg. Volume i10,820,067480
90 Day Avg. Volume i6,992,452551
Last Close$0.30$40.02
52 Week Range$0.25 - $34.08$37.27 - $52.90
% from 52W High-99.13%-24.35%
All-Time High$34.08 (Dec 02, 2024)$71.40 (Jun 11, 2018)
% from All-Time High-99.12%-43.95%
Growth Metrics
Quarterly Revenue GrowthN/A-0.02%
Quarterly Earnings GrowthN/A-0.02%
Financial Health
Profit Margin (TTM) i0.37%0.06%
Operating Margin (TTM) i-1.59%0.08%
Return on Equity (TTM) i-2.34%0.13%
Debt to Equity (MRQ) i0.64126.20
Cash & Liquidity
Book Value per Share (MRQ)$1.39$13.77
Cash per Share (MRQ)N/A$1.55
Operating Cash Flow (TTM) i$-36,835,261$206.30M
Levered Free Cash Flow (TTM) i$-85,004,692$135.97M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: TNL Mediagene vs John Wiley & Sons

MetricTNMGWLYB
Price Ratios
P/E Ratio (TTM) iN/A22.86
Forward P/E iN/AN/A
PEG Ratio iN/A-0.03
Price to Sales (TTM) i0.201.30
Price to Book (MRQ) i0.212.95
Market Capitalization
Market Capitalization i$9.54M$2.13B
Enterprise Value i$29.03M$3.01B
Enterprise Value Metrics
Enterprise to Revenue i0.601.80
Enterprise to EBITDA i-0.659.89
Risk & Other Metrics
Beta iN/A1.04
Book Value per Share (MRQ) i$1.39$13.77

Financial Statements Comparison: TNL Mediagene vs John Wiley & Sons

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TNMGWLYB
Revenue/Sales iN/A$396.80M
Cost of Goods Sold iN/A$109.26M
Gross Profit iN/A$287.54M
Research & Development iN/AN/A
Operating Income (EBIT) iN/A$34.00M
EBITDA iN/A$70.32M
Pre-Tax Income iN/A$17.71M
Income Tax iN/A$6.01M
Net Income (Profit) iN/A$11.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TNMGWLYB
Cash & Equivalents i$3.65M$85.88M
Total Current Assets i$17.72M$439.88M
Total Current Liabilities i$32.99M$820.86M
Long-Term Debt i$10.39M$870.92M
Total Shareholders Equity i$36.40M$752.21M
Retained Earnings i$-117.21M$1.59B
Property, Plant & Equipment i$100,203$66.13M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TNMGWLYB
Operating Cash Flow iN/A$110.07M
Capital Expenditures iN/A$-19.13M
Free Cash Flow iN/A$125.11M
Debt Repayment iN/A$-253.68M
Common Stock Repurchase iN/A$-25.00M

Short Interest & Institutional Ownership Analysis

MetricTNMGWLYB
Shares Short i54,828766
Short Ratio i0.024.82
Short % of Float iN/A0.00%
Average Daily Volume (10 Day) i10,820,067480
Average Daily Volume (90 Day) i6,992,452551
Shares Outstanding i26.13M53.39M
Float Shares iN/A40.19M
% Held by Insiders i0.00%0.94%
% Held by Institutions i0.01%0.03%

Dividend Analysis & Yield Comparison: TNL Mediagene vs John Wiley & Sons

MetricTNMGWLYB
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.93
3-Year Avg Dividend Yield iN/A0.99%
3-Year Total Dividends iN/A$2.80
Ex-Dividend DateN/ADec 26, 2023